Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Paired study of 172 cases of nasopharyngeal carcinoma with or without dermatomyositis.

Huang PY, Zhong ZL, Luo DH, Mai HQ, Chen MY, Li YX, Yang J, Mo HY.

Acta Otolaryngol. 2014 Aug;134(8):824-30. doi: 10.3109/00016489.2014.913312. Epub 2014 Jun 9.

PMID:
24909624
[PubMed - in process]
2.

Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.

Ling W, Cao SM, Huang QH, Li YH, Deng MQ.

Ai Zheng. 2009 Jan;28(1):57-9. Epub 2009 Jan 24.

PMID:
19448418
[PubMed - indexed for MEDLINE]
3.

Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.

Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.

Cancer. 2004 Mar 15;100(6):1162-70.

PMID:
15022282
[PubMed - indexed for MEDLINE]
Free Article
4.

Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).

Liu MT, Yeh CY.

Radiat Med. 1998 Mar-Apr;16(2):113-7.

PMID:
9650898
[PubMed - indexed for MEDLINE]
5.

[Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].

Cao SM, Min HQ, Gao JS, Hong MH, Xiao XB, Zhang CQ, Liu XD, Zhang AL, Guo X.

Ai Zheng. 2003 Mar;22(3):302-6. Chinese.

PMID:
12654192
[PubMed - indexed for MEDLINE]
6.

Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.

Hadar T, Rahima M, Kahan E, Sidi J, Rakowsky E, Sarov B, Sarov I.

J Med Virol. 1986 Dec;20(4):329-39.

PMID:
3025351
[PubMed - indexed for MEDLINE]
7.

Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.

Tamada A, Makimoto K, Yamabe H, Imai J, Hinuma Y, Oyagi A, Araki T.

Cancer. 1984 Feb 1;53(3):430-40.

PMID:
6318948
[PubMed - indexed for MEDLINE]
8.

Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.

Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, Hu LF, Zeng YX.

Anticancer Res. 2001 Jul-Aug;21(4B):3021-9.

PMID:
11712805
[PubMed - indexed for MEDLINE]
9.

Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.

Tiwawech D, Srivatanakul P, Karaluk A, Ishida T.

Asian Pac J Cancer Prev. 2003 Apr-Jun;4(2):113-8.

PMID:
12875623
[PubMed - indexed for MEDLINE]
Free Article
10.

[Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma].

Luo YL, Chen H, Peng SG, Lin JH, Huang PY.

Zhonghua Yi Xue Za Zhi. 2013 Nov 26;93(44):3516-9. Chinese.

PMID:
24521892
[PubMed - indexed for MEDLINE]
11.

[Prognostic significance of serum anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma].

Cai YL, Li J, Lu AY, Zhong WM, Zheng YM, Gao JQ, Zeng H, Chen WS, Liang W, Tang MZ.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013 Apr;27(2):119-22. Chinese.

PMID:
24044217
[PubMed - indexed for MEDLINE]
12.

[Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients].

Jiang LN, Dai LC, He JF, Chen YW, Ma ZH.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2006 Jun;20(2):30-2. Chinese.

PMID:
16816858
[PubMed - indexed for MEDLINE]
13.

Serologic diagnosis of nasopharyngeal carcinoma. A double-blind study of four EB virus antibodies with evaluation by sequential discrimination.

Cai WM, Li YW, Wu B, Liu YY, Hu YH, Gu XZ, Liu HY, Wang GD.

Int J Radiat Oncol Biol Phys. 1983 Dec;9(12):1763-8.

PMID:
6319338
[PubMed - indexed for MEDLINE]
14.

[Assay of Epstein-Barr virus in nasopharyngeal tissues and serum of patients with nasopharyngeal carcinoma].

Li XM, Yang CZ, Chen PJ, Su ZL, Song Y.

Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2000 Sep;14(9):400-1. Chinese.

PMID:
12563909
[PubMed - indexed for MEDLINE]
15.

Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.

Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M.

J Clin Virol. 2008 Feb;41(2):96-103. Epub 2007 Nov 19.

PMID:
18024156
[PubMed - indexed for MEDLINE]
16.

Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.

Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM.

J Clin Microbiol. 2006 Apr;44(4):1459-67.

PMID:
16597877
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.

Tsang RK, Vlantis AC, Ho RW, Tam JS, To KF, van Hasselt CA.

Head Neck. 2004 Jul;26(7):598-602.

PMID:
15229902
[PubMed - indexed for MEDLINE]
18.

Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody.

Leung SF, Tam JS, Chan AT, Zee B, Chan LY, Huang DP, Van Hasselt A, Johnson PJ, Lo YM.

Clin Chem. 2004 Feb;50(2):339-45. Epub 2003 Dec 18.

PMID:
14684618
[PubMed - indexed for MEDLINE]
Free Article
19.

Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.

Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC.

Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):130-7. Epub 2006 Sep 18.

PMID:
16979842
[PubMed - indexed for MEDLINE]
20.

Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.

Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.

Oral Oncol. 2008 Aug;44(8):784-92. doi: 10.1016/j.oraloncology.2007.10.003. Epub 2008 Feb 21.

PMID:
18206420
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk